Treatment With Lactobacillus Rhamnosus and Lactobacillus Acidophilus for Patients With Active Colonic Crohn's Disease.
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study is to determine whether a probiotic containing Lactobacillus Acidophilus and Lactobacillus Rhamnosus is effective as treatment for patients with active colonic Crohn's disease
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2001
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2001
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 7, 2006
CompletedFirst Posted
Study publicly available on registry
September 11, 2006
CompletedSeptember 11, 2006
April 1, 2006
September 7, 2006
September 7, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Decrease in CDAI
Secondary Outcomes (1)
Increase in IBDQ
Interventions
Eligibility Criteria
You may qualify if:
- Previously diagnosed Crohn's disease of the large bowel or large and small bowel according to established criteria.
- At least one prior episode of active disease
- Stoolcultures and microscopies without pathogenic bacteria or parasites
- CDAI 220-400
- Informed consent
You may not qualify if:
- More than 15mg of prednisolone daily (or equivalent)
- Symptoms of Crohn's disease assumed to be caused by mechanical obstruction og abscesses
- Long term treatment with NSAID or colestyramine
- Pregnant and lactating women
- Bowel resections removing more than 100 centimetres of small intestine or any colonic resection other than ileo-cecal resection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Odense University Hospitallead
- University of Southern Denmarkcollaborator
Study Sites (1)
Dept. of Medical Gastroenterology (afd.S), Odense University Hospital
Odense, 5000 C, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lone G Klinge
Odense University Hospital
- PRINCIPAL INVESTIGATOR
Jens Kjeldsen, MD, PhD
Odense University Hospital
- STUDY CHAIR
Karsten Lauritsen
Odense University Hospital
- PRINCIPAL INVESTIGATOR
Ole Oestergaard-Thomsen
Herlev Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 7, 2006
First Posted
September 11, 2006
Study Start
May 1, 2001
Study Completion
November 1, 2005
Last Updated
September 11, 2006
Record last verified: 2006-04